Another study done by Wang et al. [19] demonstrated EVI1 overexpression in both estrogen receptor-positive (ER +) and estrogen receptor-negative (ER −) breast carcinomas by analyzing a tissue microarray of 608 breast carcinoma patient specimens. This evidence concerns the gene MECOM and breast carcinoma.